N-[[(1R,2S,3R,4S)-4-hydroxy-2-phenyl-6-pyrazin-2-yl-6-azaspiro[2.4]heptan-1-yl]methyl]-1H-pyrazole-5-carboxamide

C21H22N6O2 — CID 162627782

IUPACN-[[(1R,2S,3R,4S)-4-hydroxy-2-phenyl-6-pyrazin-2-yl-6-azaspiro[2.4]heptan-1-yl]methyl]-1H-pyrazole-5-carboxamide
SMILESO=C(NC[C@@H]1[C@@H](c2ccccc2)[C@]12CN(c1cnccn1)C[C@H]2O)c1ccn[nH]1
InChIInChI=1S/C21H22N6O2/c28-17-12-27(18-11-22-8-9-23-18)13-21(17)15(19(21)14-4-2-1-3-5-14)10-24-20(29)16-6-7-25-26-16/h1-9,11,15,17,19,28H,10,12-13H2,(H,24,29)(H,25,26)/t15-,17-,19-,21-/m1/s1
InChIKeyCNWDWLRUNCTYBO-STQYRHOTSA-N
MW390.45 g/mol
LogP1.21
Rot. Bonds5

About N-[[(1R,2S,3R,4S)-4-hydroxy-2-phenyl-6-pyrazin-2-yl-6-azaspiro[2.4]heptan-1-yl]methyl]-1H-pyrazole-5-carboxamide

N-[[(1R,2S,3R,4S)-4-hydroxy-2-phenyl-6-pyrazin-2-yl-6-azaspiro[2.4]heptan-1-yl]methyl]-1H-pyrazole-5-carboxamide (PubChem CID 162627782) has the molecular formula C21H22N6O2 and a molecular weight of 390.45 g/mol. Its IUPAC name is N-[[(1R,2S,3R,4S)-4-hydroxy-2-phenyl-6-pyrazin-2-yl-6-azaspiro[2.4]heptan-1-yl]methyl]-1H-pyrazole-5-carboxamide.

Molecular Properties

Compound NameN-[[(1R,2S,3R,4S)-4-hydroxy-2-phenyl-6-pyrazin-2-yl-6-azaspiro[2.4]heptan-1-yl]methyl]-1H-pyrazole-5-carboxamide
PubChem CID162627782
Molecular FormulaC21H22N6O2
Molecular Weight390.45 g/mol
Exact Mass390.18
IUPAC NameN-[[(1R,2S,3R,4S)-4-hydroxy-2-phenyl-6-pyrazin-2-yl-6-azaspiro[2.4]heptan-1-yl]methyl]-1H-pyrazole-5-carboxamide
SMILESO=C(NC[C@@H]1[C@@H](c2ccccc2)[C@]12CN(c1cnccn1)C[C@H]2O)c1ccn[nH]1
InChIInChI=1S/C21H22N6O2/c28-17-12-27(18-11-22-8-9-23-18)13-21(17)15(19(21)14-4-2-1-3-5-14)10-24-20(29)16-6-7-25-26-16/h1-9,11,15,17,19,28H,10,12-13H2,(H,24,29)(H,25,26)/t15-,17-,19-,21-/m1/s1
InChIKeyCNWDWLRUNCTYBO-STQYRHOTSA-N
XLogP1.21
TPSA107.03 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds5
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500390.45
LogP ≤ 51.21
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Analyze N-[[(1R,2S,3R,4S)-4-hydroxy-2-phenyl-6-pyrazin-2-yl-6-azaspiro[2.4]heptan-1-yl]methyl]-1H-pyrazole-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[[(1R,2S,3R,4S)-4-hydroxy-2-phenyl-6-pyrazin-2-yl-6-azaspiro[2.4]heptan-1-yl]methyl]-1H-pyrazole-5-carboxamide?
The IUPAC name of N-[[(1R,2S,3R,4S)-4-hydroxy-2-phenyl-6-pyrazin-2-yl-6-azaspiro[2.4]heptan-1-yl]methyl]-1H-pyrazole-5-carboxamide (CID 162627782) is N-[[(1R,2S,3R,4S)-4-hydroxy-2-phenyl-6-pyrazin-2-yl-6-azaspiro[2.4]heptan-1-yl]methyl]-1H-pyrazole-5-carboxamide.
What is the SMILES notation for N-[[(1R,2S,3R,4S)-4-hydroxy-2-phenyl-6-pyrazin-2-yl-6-azaspiro[2.4]heptan-1-yl]methyl]-1H-pyrazole-5-carboxamide?
The canonical SMILES for N-[[(1R,2S,3R,4S)-4-hydroxy-2-phenyl-6-pyrazin-2-yl-6-azaspiro[2.4]heptan-1-yl]methyl]-1H-pyrazole-5-carboxamide is O=C(NC[C@@H]1[C@@H](c2ccccc2)[C@]12CN(c1cnccn1)C[C@H]2O)c1ccn[nH]1.
What is the InChIKey of N-[[(1R,2S,3R,4S)-4-hydroxy-2-phenyl-6-pyrazin-2-yl-6-azaspiro[2.4]heptan-1-yl]methyl]-1H-pyrazole-5-carboxamide?
The InChIKey is CNWDWLRUNCTYBO-STQYRHOTSA-N. The full InChI is InChI=1S/C21H22N6O2/c28-17-12-27(18-11-22-8-9-23-18)13-21(17)15(19(21)14-4-2-1-3-5-14)10-24-20(29)16-6-7-25-26-16/h1-9,11,15,17,19,28H,10,12-13H2,(H,24,29)(H,25,26)/t15-,17-,19-,21-/m1/s1.
What are the key properties of N-[[(1R,2S,3R,4S)-4-hydroxy-2-phenyl-6-pyrazin-2-yl-6-azaspiro[2.4]heptan-1-yl]methyl]-1H-pyrazole-5-carboxamide?
N-[[(1R,2S,3R,4S)-4-hydroxy-2-phenyl-6-pyrazin-2-yl-6-azaspiro[2.4]heptan-1-yl]methyl]-1H-pyrazole-5-carboxamide has a molecular weight of 390.45 g/mol, XLogP of 1.21, 5 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[(1R,2S,3R,4S)-4-hydroxy-2-phenyl-6-pyrazin-2-yl-6-azaspiro[2.4]heptan-1-yl]methyl]-1H-pyrazole-5-carboxamide is sourced from PubChem (CID 162627782), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).